Ono Pharmaceutical Co., Ltd.
OPHLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $152,093 | $17,673,000 | -$6,545,000 | $14,951,000 |
| Dep. & Amort. | $62,956 | $9,238,000 | $8,728,000 | $9,170,000 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $84,236 | $799,000 | $16,583,000 | -$1,502,000 |
| Other Non-Cash | $46,766 | -$27,686,595 | $20,230,000 | -$13,879,000 |
| Operating Cash Flow | $346,051 | $3,373,000 | $38,996,000 | $8,740,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13,439 | -$2,250,000 | -$1,421,000 | -$1,204,000 |
| Net Acquisitions | $47 | $0 | $0 | $0 |
| Inv. Purchases | -$8,538 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $32,475 | $0 | $0 | $0 |
| Other Inv. Act. | -$2,258 | $1,951,325 | $16,747,000 | $10,023,000 |
| Investing Cash Flow | $8,288 | -$298,675 | $15,326,000 | $8,819,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$50,700 | -$8,354,000 | -$8,306,000 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$7 | $0 | $0 | $0 |
| Dividends Paid | -$9,254 | -$17,396,000 | -$992,000 | -$17,770,000 |
| Other Fin. Act. | -$5,638 | $25,571,272 | $0 | -$8,320,000 |
| Financing Cash Flow | -$65,599 | -$178,728 | -$9,298,000 | -$26,090,000 |
| Forex Effect | -$22,473 | $54,813 | -$1,442,000 | $2,424,000 |
| Net Chg. in Cash | $266,267 | $138,991,000 | $43,585,000 | $160,982,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $964,459 | $0 | $160,982,000 | $0 |
| End Cash | $1,230,726 | $138,991,000 | $204,567,000 | $160,982,000 |
| Free Cash Flow | $334,830 | $1,123,000 | $37,575,000 | $7,536,000 |